An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy.
Saved in:
| Title: | An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy. |
|---|---|
| Authors: | Janes PW; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3083, Australia., Parslow AC; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Cao D; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Rigopoulos A; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Lee FT; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Gong SJ; School of Computing, Engineering and Mathematical Sciences, La Trobe University, Melbourne, VIC 3083, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC 3084, Australia., Cartwright GA; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Burvenich IJG; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3083, Australia., Eriksson U; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Solna, Sweden., Johns TG; Oncogenic Signalling Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Nedlands, WA 6009, Australia.; Medical School, University of Western Australia, Crawley, WA 6009, Australia., Scott FE; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Scott AM; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3083, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC 3084, Australia.; Department of Medicine, University of Melbourne, Parkville, VIC 3052, Australia. |
| Source: | Cancers [Cancers (Basel)] 2024 May 16; Vol. 16 (10). Date of Electronic Publication: 2024 May 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
